Want to see JP:3636 full AI Analyst Report?
3636 Stock Chart & Stats
¥4860.00
-¥5.00(-0.10%)
At close: 4:00 PM EST
¥4860.00
-¥5.00(-0.10%)
Day’s Range― - ―
52-Week Range¥4,375.00 - ¥5,360.00
Previous CloseN/A
Volume35.50K
Average Volume (3M)52.88K
Market Cap
¥79.48B
Enterprise Value¥38.21K
Total Cash (Recent Filing)¥41.91B
Total Debt (Recent Filing)¥982.00M
Price to Earnings (P/E)9.6
Beta0.69
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.27%
Share Statistics
EPS (TTM)525.61
Shares Outstanding16,044,000
10 Day Avg. Volume41,960
30 Day Avg. Volume52,880
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)1.13
Price to Sales (P/S)0.67
P/FCF Ratio29.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)420.2
Revenue Forecast (FY)¥126.61B
Bulls Say, Bears Say
Bulls Say
Revenue And Margin ImprovementSustained top-line growth alongside higher gross margins and positive EBIT/EBITDA trends indicates MRI is converting demand into more efficient delivery, supporting durable earnings quality across consulting, research and systems-integration work.
Conservative Balance SheetMinimal leverage gives MRI substantial financial resilience and flexibility to fund technology investment, absorb project timing changes, and pursue growth without relying heavily on external borrowing or increasing interest costs.
Healthy Operating Cash GenerationHealthy operating cash flow and stable conversion relative to net income indicate that reported profits are generally supported by cash generation. This strengthens MRI’s ability to fund operations and maintain client delivery capabilities.
Bears Say
Declining Free Cash Flow GrowthWeaker free cash flow growth and lower conversion of earnings into free cash may constrain internally funded investment over time. If sustained, this could reduce flexibility for platform development, acquisitions or shareholder returns.
Lower Return On EquityA declining ROE indicates that MRI is producing somewhat less profit from its equity base, which may reflect underutilized capital or slower earnings efficiency. Improvement in returns will be important for sustaining long-term shareholder value.
Dependence On Commissioned ProjectsReliance on commissioned research, public-sector programs and project-based systems work can make revenue dependent on procurement cycles, budgets and contract timing. This may limit predictability compared with recurring subscription-based models.
Mitsubishi Research Institute News
3636 FAQ
What was Mitsubishi Research Institute’s price range in the past 12 months?
Mitsubishi Research Institute lowest stock price was ¥4375.00 and its highest was ¥5360.00 in the past 12 months.
What is Mitsubishi Research Institute’s market cap?
Mitsubishi Research Institute’s market cap is ¥79.48B.
When is Mitsubishi Research Institute’s upcoming earnings report date?
Mitsubishi Research Institute’s upcoming earnings report date is Nov 04, 2026 which is in 59 days.
How were Mitsubishi Research Institute’s earnings last quarter?
Mitsubishi Research Institute released its earnings results on Jul 29, 2026. The company reported -¥100.96 earnings per share for the quarter.
Is Mitsubishi Research Institute overvalued?
According to Wall Street analysts Mitsubishi Research Institute’s price is currently Overvalued.
Does Mitsubishi Research Institute pay dividends?
Mitsubishi Research Institute pays a Semiannually dividend of ¥85 which represents an annual dividend yield of 3.27%. See more information on Mitsubishi Research Institute dividends here
What is Mitsubishi Research Institute’s EPS estimate?
Mitsubishi Research Institute’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mitsubishi Research Institute have?
Mitsubishi Research Institute has 16,044,000 shares outstanding.
What happened to Mitsubishi Research Institute’s price movement after its last earnings report?
Mitsubishi Research Institute reported an EPS of -¥100.96 in its last earnings report. Following the earnings report the stock price went up 2.758%.
Which hedge fund is a major shareholder of Mitsubishi Research Institute?
Currently, no hedge funds are holding shares in JP:3636
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mitsubishi Research Institute
Mitsubishi Research Institute, Inc. (MRI) is a Japanese firm that delivers a wide array of strategic advisory, information technology, and research services. It caters to a diverse client base within Japan, encompassing governmental entities, financial organizations, and private corporations. The company's extensive solutions span areas such as management consultation, digital and financial innovation, environmental and energy initiatives, healthcare and wellness, regional development, future infrastructure deployment, scientific and safety research, nuclear safety, and broad economic, social, and R&D initiatives. Furthermore, MRI handles specialized project engagements and public sector procurement. In a key collaboration, it partners with ForePaaS SAS to implement cloud-native data-intensive solutions across Japan. Established in 1970, Mitsubishi Research Institute, Inc. is headquartered in Tokyo.